This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Johns Hopkins University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Mark J Ranek: Innovator in Engineered TSC2 Polypeptides
Introduction
Mark J Ranek is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered TSC2 polypeptides. His work has implications for the understanding and treatment of various diseases.
Latest Patents
Mark J Ranek holds 1 patent related to his innovative research. The patent, titled "Engineered TSC2," provides engineered TSC2 polypeptides and nucleic acid sequences encoding them. This invention alters the ability of a serine residue to be phosphorylated, which can have profound effects on cellular functions. The patent also includes engineered immune cells that incorporate these altered TSC2 polypeptides or nucleic acid sequences, along with methods for their production and application.
Career Highlights
Ranek is affiliated with Johns Hopkins University, where he continues to advance his research in biotechnology. His work is characterized by a commitment to innovation and a focus on practical applications of his inventions.
Collaborations
Throughout his career, Mark J Ranek has collaborated with esteemed colleagues, including David A Kass and Jonathan David Powell. These collaborations have enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
Mark J Ranek's contributions to the field of engineered TSC2 polypeptides highlight his role as an innovator in biotechnology. His patent and ongoing research at Johns Hopkins University demonstrate his commitment to advancing scientific understanding and improving health outcomes.